Simons K J, Chen X, Fraser T G, Simons F E
Health Sciences Clinical Research Centre, Faculties of Pharmacy, Science, and Medicine, University of Manitoba, Winnipeg, Canada.
Pharm Res. 1996 Feb;13(2):301-4. doi: 10.1023/a:1016011702703.
The effects of concomitant administration of the H2-receptor antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-receptor antagonists chlorpheniramine and diphenhydramine were studied in rabbits.
A single dose of chlorpheniramine 10 mg (Group A) or diphenhydramine 10 mg (Group B) was given intravenously on three different study days as follows: 2 weeks before cimetidine administration, after giving cimetidine 100 mg/kg intravenously every 12 hours for one week, and two weeks after discontinuing the cimetidine. Serum chlorpheniramine and diphenhydramine concentrations were measured by HPLC. Histamine H1-blockade was assessed by measuring suppression of the histamine-induced wheals in the skin.
The chlorpheniramine and diphenhydramine terminal elimination half-life values and area under the curve values were significantly increased, and the systemic clearance rates were significantly decreased, during concomitant administration of cimetidine. For each H1-receptor antagonist, pharmacokinetic parameters were similar before cimetidine was co-administered and two weeks after cimetidine was discontinued. Wheal suppression produced by chlorpheniramine or diphenhydramine was increased and prolonged when cimetidine was administered concomitantly.
Any enhanced peripheral H1-blockade observed could be attributed, at least in part, to a pharmacokinetic interaction.
在兔体内研究H2受体拮抗剂西咪替丁与H1受体拮抗剂氯苯那敏和苯海拉明联合给药对其药代动力学和药效动力学的影响。
在三个不同的研究日静脉注射单剂量的10 mg氯苯那敏(A组)或10 mg苯海拉明(B组),具体如下:在给予西咪替丁前2周、静脉注射100 mg/kg西咪替丁,每12小时一次,持续一周后以及停用西咪替丁两周后。通过高效液相色谱法测定血清氯苯那敏和苯海拉明浓度。通过测量组胺诱导的皮肤风团抑制情况评估组胺H1受体阻断作用。
在联合使用西咪替丁期间,氯苯那敏和苯海拉明的末端消除半衰期值和曲线下面积值显著增加,全身清除率显著降低。对于每种H1受体拮抗剂,在联合使用西咪替丁前和停用西咪替丁两周后的药代动力学参数相似。联合使用西咪替丁时,氯苯那敏或苯海拉明产生的风团抑制作用增强且持续时间延长。
观察到的外周H1受体阻断作用增强至少部分可归因于药代动力学相互作用。